Abivax is advancing obefazimod, a first-in-class oral therapy for UC and CD, with major upcoming data catalysts. Click here ...
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript March 18, 2026 Hyperfine, Inc. beats earnings expectations. Reported EPS is $-0.06276, expectations were $-0.08. Operator: Hello, and ...
A cult classic rock drama blends coming of age heart with sex, drugs, and music, turning a box office flop into a timeless ...
Anne Hathaway made sure producers of The Devil Wears Prada 2 didn't feature "skeletal" models that were "alarmingly thin." ...
Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...
Some of The Leading Ladies From hospitality and fashion to art, entrepreneurship and giving back NEW YORK, NY, UNITED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results